Jazz Pharmaceuticals plc (JAZZ) Operating margin 2016–2025
Jazz Pharmaceuticals plc (JAZZ) operating margin by fiscal year — reported operating income divided by reported revenue.
-10.1%FY2025 · since FY2016: 39.8% → -10.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -10.1% | -27.7 pp |
| FY2024 | 17.6% | +2.5 pp |
| FY2023 | 15.1% | +16.9 pp |
| FY2022 | -1.8% | -7.3 pp |
| FY2021 | 5.5% | -10.5 pp |
| FY2020 | 16.0% | -8.6 pp |
| FY2019 | 24.6% | -7.9 pp |
| FY2018 | 32.5% | -0.2 pp |
| FY2017 | 32.7% | -7.1 pp |
| FY2016 | 39.8% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice